EARNING RECAP

Activision Blizzard Inc

#ATVI 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q1 adjusted 78c est. 26c $1.26B est. $1.24B -4.84% ($47.15 closing price) $48.67 $46.16 sees Q2 adjusted EPS 35c est. 37c;Q2 revenue $1.15B est. $1.28B; Fy19 EPS view $1.85 est. $2.19; Fy19 net bookings $6.3B est. $6.41B
#ATVI 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 90c est. $1.28 $2.84B est. $3.04B +6.96% ($44.57 closing price) $45.33 $42.84 sees Q1 EPS 63c est. 46c revenue $1.715B est. $1.46B; sees FY19 EPS $1.85 est. $2.58 FY19 bookings $6.30B est. $7.03B; authorizes 2yr $1.5B stock buyback
Q3 adjusted 42c est. 50c $1.66B est. $1.66B -12.39% ($55.01 closing price) $56.92 $53.50 sees Q4 adjusted EPS 64c est. $1.34 Q4 bookings $3.05B est. $3.06B; backs FY18 EPS adjusted EPS view $2.46 est. $2.64; reports Q3 MAU at 345M
Q2 adjusted 62c est. 35c $1.38B est. 41.38B -3.70% ($71.32 closing) $75.25 $70.73 Guidance: Q3 adjusted EPS 37c, est. 66c Sees Q3 net bookings $1.61B,est. $1.87B; FY18 adjusted EPS $2.46, consensus $2.60 Backs FY18 net bookings view $7.48B est. $7.52B.
Q1 adjusted 38c est. 35c $1.384B est. $1.32B +4.52% ($69.84 closing) $69.92 $66.02 sees FY18 adjusted EPS $2.51 est. $2.62; revenue $7.475B est. $7.51B; Q2 EPS adj. 31c est. 47c; rev $1.35B est. $1.48B
#ATVI 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 49c est. 93c $2.04B est. $2.55B -5.23% ($65.83 closing) $69.79 $65.76 raises quarterly dividend to 34c per share or 13%
Q3 47c vs 49c GAAP revenue $1.62b vs $1.72B -3.44% ($63.20 closing) $67.03 $62.11 sees FY18 EPS 42.08 vs $2.13.
Q2 55c vs. 30c $1.63Bil vs. $1.22Bil -3.06% $63.30 $61.22
Q1 Non-GAAP EPS $72C Vs $21c $1.73B vs 1.09B +1.37% ($53.83 closing) $54.75 $53.08 -0.43% @ $52.87 AH. CY17 non-GAAP EPS view to $1.80

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.